Annual ROE
3.19%
-3.47%-52.10%
December 31, 2024
Summary
- As of March 13, 2025, ENFN annual return on equity is 3.19%, with the most recent change of -3.47% (-52.10%) on December 31, 2024.
- During the last 3 years, ENFN annual ROE has risen by +289.50% (+101.11%).
- ENFN annual ROE is now -52.10% below its all-time high of 6.66%, reached on December 31, 2023.
Performance
ENFN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
3.17%
-0.80%-20.15%
December 31, 2024
Summary
- As of March 13, 2025, ENFN quarterly return on equity is 3.17%, with the most recent change of -0.80% (-20.15%) on December 31, 2024.
- Over the past year, ENFN quarterly ROE has dropped by -3.91% (-55.23%).
- ENFN quarterly ROE is now -99.73% below its all-time high of 1169.28%, reached on June 30, 2022.
Performance
ENFN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ENFN ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -52.1% | -55.2% |
| 3 y3 years | +101.1% | -51.5% |
| 5 y5 years | +129.7% | -51.5% |
ENFN ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -52.1% | +101.1% | -99.7% | +100.6% |
| 5 y | 5-year | -52.1% | +101.1% | -99.7% | +100.6% |
| alltime | all time | -52.1% | +101.1% | -99.7% | +100.6% |
Enfusion ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | 3.19%(-52.1%) | 3.17%(-20.2%) |
| Sep 2024 | - | 3.97%(-16.1%) |
| Jun 2024 | - | 4.73%(+50.6%) |
| Mar 2024 | - | 3.14%(-55.6%) |
| Dec 2023 | 6.66%(-187.4%) | 7.08%(+8.4%) |
| Sep 2023 | - | 6.53%(+11.2%) |
| Jun 2023 | - | 5.87%(+131.1%) |
| Mar 2023 | - | 2.54%(-133.2%) |
| Dec 2022 | -7.62% | -7.65%(-98.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -531.72%(-145.5%) |
| Jun 2022 | - | 1169.28%(+503.5%) |
| Mar 2022 | - | 193.74%(+65.3%) |
| Dec 2021 | -286.31%(>+9900.0%) | 117.21%(>+9900.0%) |
| Sep 2021 | - | 0.23%(-130.7%) |
| Jun 2021 | - | -0.75%(-170.1%) |
| Mar 2021 | - | 1.07%(-62.2%) |
| Dec 2020 | -1.74%(-83.8%) | 2.83% |
| Dec 2019 | -10.74% | - |
FAQ
- What is Enfusion annual return on equity?
- What is the all time high annual ROE for Enfusion?
- What is Enfusion annual ROE year-on-year change?
- What is Enfusion quarterly return on equity?
- What is the all time high quarterly ROE for Enfusion?
- What is Enfusion quarterly ROE year-on-year change?
What is Enfusion annual return on equity?
The current annual ROE of ENFN is 3.19%
What is the all time high annual ROE for Enfusion?
Enfusion all-time high annual return on equity is 6.66%
What is Enfusion annual ROE year-on-year change?
Over the past year, ENFN annual return on equity has changed by -3.47% (-52.10%)
What is Enfusion quarterly return on equity?
The current quarterly ROE of ENFN is 3.17%
What is the all time high quarterly ROE for Enfusion?
Enfusion all-time high quarterly return on equity is 1169.28%
What is Enfusion quarterly ROE year-on-year change?
Over the past year, ENFN quarterly return on equity has changed by -3.91% (-55.23%)